Clinical Trial Update: Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating GSK2197870A vaccine given as a primary course in infants has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Infection
• Meningococcal Disease

Drugs mentioned

• GSK2197870A Vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neisseria Meningitidis, Haemophilus Influenzae Type b | Phase 2 | Status: COMPLETED | Results posted: 2014-07-28